[ad_1]
Phoenix-based Dot Compliance, which offers an AI-powered high quality administration system for compliance, introduced it closed $17 million in Sequence B extension funding, bringing its whole funding to $50 million.
The funding spherical was led by present buyers IGP Capital and Vertex Ventures with further funding from TPY Capital.
WHAT IT DOES
Dot Compliance AI options present a vendor-neutral eQMS platform for compliance wants, which incorporates doc, change and provider high quality administration. Compliance laws and requirements that the options handle embody FDA 21 CFR Half II, FDA 21 CFR Half 820 and EU GMP Annex II.
Dot Compliance will use the funds to additional develop its AI options and drive buyer acquisition and innovation.
“We’re thrilled about this new part of development in Dot Compliance’s evolution. From the preliminary launch of our high quality administration platform to our AI-enabled options…to our transformation to a knowledge firm, Dot Compliance continues to be on the forefront of innovation. We’re excited for this new journey and grateful for the continued assist of our buyers,” Mickey Landkof, basic supervisor and world VP of gross sales at Dot Compliance, advised MobiHealthNews in an electronic mail.
MARKET SNAPSHOT
Dot Compliance was based in 2015 and launched its generative AI eQMS answer, Dottie AI, in 2023.
Opponents within the eQMS house embody AI-driven Mind and Eire-based Qualio.
Mind launched its AI-powered eQMS platform in September of 2023, known as Mind AI. The eQMS software program makes use of OpenAI and ChatGPT for its AI assistant to make high quality and security extra environment friendly with out using coding.
In 2021, Cork-based Qualio secured $50 million in a Sequence B funding spherical. The spherical was led by Tiger International and Menlo Ventures with further assist from present buyers Storm Ventures, MHS Capital, Sorenson Ventures and Frontline Ventures.
[ad_2]
Source link
